Indonesia vs Madagascar: Treatment coverage for schistosomiasis
Indonesia
40.5%
in 2024
Madagascar
41.4%
in 2024
Indonesia rank
27th
Madagascar rank
26th
Treatment coverage for schistosomiasis over time
- Indonesia
- Madagascar
How they compare
Madagascar currently reports 41.4% against 40.5% in Indonesia, a difference of 0.9%.
The two have swapped places 5 times across 10 shared years of data; in 2011 it was Indonesia ahead.
Indonesia ranks 27th and Madagascar ranks 26th of 45 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and Madagascar in 1.
Head to head by decade
| Decade | Indonesia | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.9% | 22.9% | 23.0% | Indonesia |
| 2020s | 13.9% | 38.4% | 24.5% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Indonesia or Madagascar?
- Madagascar, at 41.4% against 40.5% in Indonesia as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Indonesia and Madagascar?
- 0.9%, with Madagascar ahead.
- How many years of comparable data are there for Indonesia and Madagascar?
- 10 years are reported by both, from 2011 to 2024.
- How do Indonesia and Madagascar rank globally for treatment coverage for schistosomiasis?
- Indonesia ranks 27th and Madagascar ranks 26th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.